Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2026-04-07 16:24:44 ET · period of report 2026-04-06 · accession 0000882796-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-07 16:24 | 2026-04-06 | BCRX | Menon Sandeep | Chief R, D Off | A - Grant | $0.00 | +205.2K | 205.2K | New | $0 |
| D | 2026-04-07 16:24 | 2026-04-06 | BCRX | Menon Sandeep | Chief R, D Off | A - Grant | $0.00 | +441.4K | 441.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-06 | A | A | 205,150 | $0.00 | 205,150 | D | — | — | (F1) Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the "Stock Incentive Plan"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. |
| 2 | Derivative | Emp. Stock Option (Right to Buy) | 2026-04-06 | A | A | 441,350 | $0.00 | 441,350 | D | $9.47 · — to 2036-04-06 | 441,350 Common Stock | (F2) Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. (F2) Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. |